Citation notice #8477 · 2026-08-05 06:18:25.580924+00:00

The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors

cites Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types, which carries a correction notice dated 2025-03-03. One-hop deterministic notice: the citation edge exists in the Pith bibliography graph; no model judged whether the citation was load-bearing.

This is not a judgment on the citing paper.

Citing paper Event page Original DOI Notice DOI File a formal challenge All reference changes

01Evidence

Raw extraction · citation context · bibliography index 4

iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol . 2017;18(3):e143 -e152. doi:10.1016/S1470-2045(17)30074-8 4. Gandara DR, Agarwal N, Gupta S, et al. Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types. J Immunother Cancer. 2025;13(2):e010311. doi:10.1136/jitc-2024-010311 5. Ngo P, Cooper WA, Wade S, et al. Why PD -L1 expression varies between studies of lung cancer: results from a Bayesian meta -analysis. Sci Rep . 2025;15(1):4166. doi:10.1038/s41598-024-80301-9 6. Dasari A, Morris VK, Allegra CJ, et al. ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal -Anal Task Forces whitepaper.

Parser render (TeX stripped for reading; raw above is the evidence)

iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol . 2017;18(3):e143 -e152. doi:10.1016/S1470-2045(17)30074-8 4. Gandara DR, Agarwal N, Gupta S, et al. Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types. J Immunother Cancer. 2025;13(2):e010311. doi:10.1136/jitc-2024-010311 5. Ngo P, Cooper WA, Wade S, et al. Why PD -L1 expression varies between studies of lung cancer: results from a Bayesian meta -analysis. Sci Rep . 2025;15(1):4166. doi:10.1038/s41598-024-80301-9 6. Dasari A, Morris VK, Allegra CJ, et al. ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal -Anal Task Forces whitepaper

02Event

Type

Correction

Source

Crossref

Original DOI

10.1136/jitc-2024-010311

Notice DOI

10.1136/jitc-2024-010311corr1

Date

2025-03-03

Title

Correction: Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types

Reasons

['Correction']

Work

Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types (2025) Journal for ImmunoTherapy of Cancer

Schema constants (for re-runners): correction · crossref

03Dispute this notice

If this citation does not depend on the flagged claim, or the event is wrong, say so. Disputes are public. For a signed challenge against the paper itself, use the formal challenge form.